Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.839
+0.019 (2.27%)
At close: Nov 4, 2024, 4:00 PM
0.845
+0.006 (0.73%)
After-hours: Nov 4, 2024, 6:55 PM EST
Lineage Cell Therapeutics Employees
As of December 31, 2023, Lineage Cell Therapeutics had 75 total employees, including 68 full-time and 7 part-time employees. The number of employees decreased by 3 or -3.85% compared to the previous year.
Employees
75
Change (1Y)
-3
Growth (1Y)
-3.85%
Revenue / Employee
$82,480
Profits / Employee
-$322,493
Market Cap
158.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Tenaya Therapeutics | 140 |
Alpha Tau Medical | 121 |
Adverum Biotechnologies | 121 |
Verastem | 73 |
Vigil Neuroscience | 69 |
Compugen | 68 |
Checkpoint Therapeutics | 23 |
Achieve Life Sciences | 22 |
LCTX News
- 21 days ago - Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit - Business Wire
- 5 weeks ago - OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium - Business Wire
- 6 weeks ago - Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop - Business Wire
- 2 months ago - Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - Business Wire
- 3 months ago - Lineage Cell Therapeutics, Inc. (LCTX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 3 months ago - Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 - Business Wire
- 4 months ago - Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index - Business Wire